Evidence map›Paper›PMID 26222692›Full record

ArticlePloS one2015

Ketamine/Xylazine-Induced Corneal Damage in Mice.

Demelza Koehn, Kacie J Meyer, Nasreen A Syed, Michael G Anderson

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  5. In Search of Mouse Models for Exfoliation Syndrome.American journal of ophthalmology · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Expression of NMNAT1 in the photoreceptors is sufficient to preventMolecular therapy. Methods & clinical development · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Demelza KoehnDepartment of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa, United States of America.
Kacie J MeyerDepartment of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa, United States of America.
Nasreen A SyedDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, United States of America; Department of Pathology, University of Iowa, Iowa City, Iowa, United States of America.
Michael G AndersonDepartment of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa, United States of America; Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, United States of America; Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, Iowa, United States of America.
University of Iowa · US

Funding

Genetics of Quantitative Traits Associated with GlaucomaR01EY018825 · NEI · UNIVERSITY OF IOWA · PI FINGERT, JOHN H · 2009 to 2013
$3.2M
Genetic dissection of pigment dispersing iris diseaseR01EY017673 · NEI · UNIVERSITY OF IOWA · PI ANDERSON, MICHAEL G · 2008 to 2017
$3.1M
Identification of molecular pathways contributing to central corneal thicknessF32EY021436 · NEI · UNIVERSITY OF IOWA · PI KOEHN, DEMELZA · 2011 to 2013
$168k
NEI NIH HHS EY017673NEI NIH HHS EY018825NEI NIH HHS EY021436NEI NIH HHS F32 EY021436NEI NIH HHS R01 EY017673NEI NIH HHS R01 EY018825
6 · The paper itself

Abstract

purposeWe have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity. The purpose of this study was to establish the clinical and histological features of this deleterious side effect, its sensitivity with respect to age and anesthesia protocol, and approaches for avoiding it.

methodsYoung C57BL/6J, C57BLKS/J, and SJL/J mice were treated with permutations of anesthesia protocols and compared using slit-lamp exams, optical coherence tomography, histologic analyses, and telemetric measurements of body temperature.

resultsKetamine/xylazine induces corneal damage in mice with a variable frequency. Among 12 experimental cohorts, corneal damage associated with ketamine/xylazine was observed in 9 of them. Despite various treatments to avoid corneal dehydration during anesthesia, the frequency of corneas experiencing damage among responding cohorts was 42% (26% inclusive of all cohorts), which is significantly greater than the natural prevalence (5%). The damage was consistent with band keratopathy. It appeared as a white or gray horizontal band located proximal to the pupil and was positive for subepithelial calcium deposition with von Kossa stain.

conclusionsThe sum of our clinical and histological observations is consistent with ketamine/xylazine-induced band keratopathy in mice. This finding is relevant for mouse studies involving the eye and/or vision-dependent behavioral assays, which would both be prone to artifact without appreciation of the damage caused by ketamine/xylazine anesthesia. Use of yohimbine is suggested as a practical means of avoiding this complication.

Indexed as

AnesthesiaAnimalsCorneaCorneal OpacityKetamineMiceXylazineKetamineXylazine

Identifiers

PMID26222692
PMCPMC4519051
OpenAlexW1932710260

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.